PF-Atlas › Clinical Trials › NCT03632525

Intravenous Iron in Adults With Cystic Fibrosis

Ferric carboxymaltose · Phase 4

Registry ID
NCT03632525
Phase
Phase 4
Status
Completed
Drug / intervention
Ferric carboxymaltose
Sponsor
University of Oxford
Start
2019-02-22
Enrollment
20
Locations
1

About this trial

This pilot interventional cohort study will examine the effects of intravenous iron in adults with cystic fibrosis and iron deficiency.

View NCT03632525 on ClinicalTrials.gov →

Explore related

All Ferric carboxymaltose trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT03632525 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.